NEW CASE STUDY Unlocking the power of process analytical technology to boost downstream operations    Dive in today!
Contact Us
Contact Us

AGC Biologics

AGC Biologics and Fondazione Telethon celebrate regulatory approvals for gene therapy

3 min read

AGC Biologics Celebrates U.S. and EU Approval of Fondazione Telethon’s Waskyra™ Treatment for Wiskott-Aldrich Syndrome

January 16, 2026 at 11:00 AM
Read press release
AGC Bio and Asimov logo with viral vector image

2 min read

Asimov and AGC Biologics Team Up to Provide a Cost-Effective, Simplified, and Secure Manufacturing Approach for Viral Vector Production

January 12, 2026 at 4:00 AM
Read press release

3 min read

AGC Biologics Partners with ATUM to Accelerate Timelines for Cell Line Development

December 2, 2025 at 6:00 AM
Read press release
AGC Biologics partners with AAVantgarde

3 min read

AGC Biologics to Manufacture AAVantgarde’s Dual-Vector Gene Therapies for Inherited Retinal Disorders

November 21, 2025 at 12:00 AM
Read press release
AGC Biologics today announced it is partnering with Repair Biotechnologies to tackle one of the world's most persistent health challenges and cause of mortality.

2 min read

AGC Biologics and Repair Biotechnologies Partner on Novel mRNA Therapeutic to Combat the Leading Cause of Human Mortality

November 19, 2025 at 12:00 AM
Press Release mRNA Content
Read press release
Three workers in AGC Biologics Milan site review fill/finish procedures

3 min read

AGC Biologics Partners with Rarity PBC to Advance Life-Saving Gene Therapy for "Bubble Baby Disease"

October 23, 2025 at 12:00 AM
Cell & Gene Therapy Press Release
Read press release
Seattle site team member hard at work

2 min read

Seattle Facility Achieves Regulatory Approvals, Customer Satisfaction and Zero-Finding ISO Certification Inspection

September 10, 2025 at 8:00 AM
Mammalian & mAbs Press Release Business Updates Microbial
Read press release
Graphic with AGC Biologics and Autolus logos and notes EU market authorization for AUCATZYL

1 min read

European Commission Approves CAR-T Therapy With Lentiviral Vectors Manufactured by AGC Biologics

July 31, 2025 at 7:00 AM
Cell & Gene Therapy Press Release
Read press release

1 min read

AGC Biologics’ Heidelberg Site Supplies Drug Substance for Phase II Studies of Valneva’s Tetravalent Shigella Vaccine Candidate

July 29, 2025 at 7:00 AM
Press Release Microbial
Read press release
AGC Bio Seattle and Chiba site buildings

1 min read

From Seattle to Chiba: Okayama University Taps AGC Biologics' Global Pathway for New Therapeutic

July 16, 2025 at 5:00 PM
Mammalian & mAbs Press Release
Read press release
1 2 3 4 5 Next